Cargando…

The Prognostic Role of the Class III β-Tubulin in Non-Small Cell Lung Cancer (NSCLC) Patients Receiving the Taxane/Vinorebine-Based Chemotherapy: A Meta-Analysis

BACKGROUND: A number of studies have examined the relationship between the expression of the class III β-tubulin (TUBB3) and the treatment responses to the taxane/vinorebine-based chemotherapy in patients with non-small cell lung cancer (NSCLC). However, the results of these studies were inconsisten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yan-Long, Luo, Xiu-Ping, Xian, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976369/ https://www.ncbi.nlm.nih.gov/pubmed/24705847 http://dx.doi.org/10.1371/journal.pone.0093997

Ejemplares similares

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors
por: Miura, Yosuke, et al.
Publicado: (2017)

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
por: Du, Jintong, et al.
Publicado: (2015)

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
por: Christoph, D C, et al.
Publicado: (2012)

High expression of class III β-tubulin in small cell lung carcinoma
por: POWELL, STEVEN, et al.
Publicado: (2014)

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands
por: Balaguer, Francisco de Asís, et al.
Publicado: (2019)

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
por: Stengel, C, et al.
Publicado: (2010)

Class III β-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration
por: Ganguly, Anutosh, et al.
Publicado: (2011)

High expression of class III β-tubulin in upper gastrointestinal cancer types
por: Höflmayer, Doris, et al.
Publicado: (2018)

Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
por: Kavallaris, M, et al.
Publicado: (1999)

Increased expression of class III β-tubulin in castration-resistant human prostate cancer
por: Terry, S, et al.
Publicado: (2009)

Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes
por: Froidevaux-Klipfel, Laurence, et al.
Publicado: (2015)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy
por: Hilaj, Erina, et al.
Publicado: (2020)

Hair follicle bulge cultures yield class III β-tubulin-positive melanoglial cells
por: Locher, H., et al.
Publicado: (2015)

Class III β-Tubulin in Colorectal Cancer: Tissue Distribution and Clinical Analysis of Chinese Patients
por: Zhao, Xiaoli, et al.
Publicado: (2016)

Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer
por: Martinelli, Enrica, et al.
Publicado: (2018)

Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line
por: Yahiro, Kenichiro, et al.
Publicado: (2018)

Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy
por: Zhang, Yi, et al.
Publicado: (2023)

Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
por: Kong, Xiang-Quan, et al.
Publicado: (2018)

High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer
por: LEBOK, PATRICK, et al.
Publicado: (2016)

High expression levels of class III β-tubulin in resected non-small cell lung cancer patients are predictive of improved patient survival after vinorelbine-based adjuvant chemotherapy
por: ZHANG, YALEI, et al.
Publicado: (2013)

Aberrant Promoter Methylation of Caveolin-1 Is Associated with Favorable Response to Taxane-Platinum Combination Chemotherapy in Advanced NSCLC
por: Brodie, Seth A., et al.
Publicado: (2014)

The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy
por: Zhou, Wenbin, et al.
Publicado: (2012)

βIII-Tubulin Gene Regulation in Health and Disease
por: Duly, Alastair M. P., et al.
Publicado: (2022)

Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer
por: Maahs, Lucas, et al.
Publicado: (2019)

EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment
por: Reader, Jocelyn, et al.
Publicado: (2019)

A prognostic 4-gene expression signature for patients with HER2-negative breast cancer receiving taxane and anthracycline-based chemotherapy
por: Cheng, Pu, et al.
Publicado: (2017)

Microtubule-Associated Protein Tau, α-Tubulin and βIII-Tubulin Expression in Breast Cancer
por: Im, Soyoung, et al.
Publicado: (2013)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis
por: Das, Lalita, et al.
Publicado: (2012)

Axonal transport of class II and III beta-tubulin: evidence that the slow component wave represents the movement of only a small fraction of the tubulin in mature motor axons
Publicado: (1992)

Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life
por: Kaizu, Mikiko, et al.
Publicado: (2021)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
por: Simsek, Neriman Yükseltürk, et al.
Publicado: (2018)

Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells
por: Tamura, Daisuke, et al.
Publicado: (2013)

Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
por: Nami, Babak, et al.
Publicado: (2018)

Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues
por: Yusof, Nor Syahida Binti, et al.
Publicado: (2017)

β class II tubulin predominates in normal and tumor breast tissues
por: Dozier, James H, et al.
Publicado: (2003)

A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer
por: Liu, Xin-Xiu, et al.
Publicado: (2022)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tl3qmt82vp2brj18j5fenoidsu